PF-AtlasClinical Trials › NCT00686361

Choline Nutrition in Children With Cystic Fibrosis

Choline supplementation · Not specified

Registry ID
NCT00686361
Phase
Not specified
Status
Completed
Drug / intervention
Choline supplementation
Sponsor
University of British Columbia
Start
2007-10
Enrollment
34
Locations
1

About this trial

Cystic Fibrosis (CF) is a complex disease with a wide range of clinical problems. Despite enzyme replacement therapy, children with cystic fibrosis (CF) may still have problems absorbing some nutrients. Detailed studies of the nutrient status of children with CF and have found low amounts of choline, an essential dietary nutrient, and altered levels of some amino acids in almost all patients. Choline is an essential dietary nutrient that is important in many important body functions, which include proving a source of methyl groups, the structure of cell membranes and in acetylcholine. Most choline is present in our diets in a fat known as phosphatidylcholine. Research studies have shown that children with cystic fibrosis do not absorb fat, including phosphatidylcholine very well. In previous studies, we showed that choline provided as a dietary supplement for 2 weeks improved choline status in children with cystic fibrosis. The purpose of this research is to find out if choline supplements over a longer duration of 6 months will improve and maintain normal choline status in children with CF.

View NCT00686361 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT00686361 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.